Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sotera Health (SHC) Shares Outstanding (Diluted Average) (2019 - 2026)

Sotera Health has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $286.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 0.53% year-over-year to $286.4 million; the TTM value through Dec 2025 reached $286.4 million, up 0.53%, while the annual FY2025 figure was $286.4 million, 0.53% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $286.4 million at Sotera Health, roughly flat from $286.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $286.4 million in Q4 2025 and troughed at $2.1 million in Q1 2024.
  • A 5-year average of $268.3 million and a median of $282.0 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 99.24% in 2024 and later skyrocketed 13094.88% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $279.4 million in 2021, then increased by 0.26% to $280.1 million in 2022, then rose by 1.12% to $283.2 million in 2023, then increased by 0.59% to $284.9 million in 2024, then rose by 0.53% to $286.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SHC at $286.4 million in Q4 2025, $286.0 million in Q3 2025, and $285.8 million in Q2 2025.